Peptides of China — our platform for china peptides sourcing — publishes short updates like this one whenever something material changes: catalog additions, quality-process notes, and sourcing announcements. The substance of this update is below.
Product Catalog Update
We have updated our product catalog with several new research compounds and removed a number of discontinued products.
Discontinued Products
Shanghai Labs has discontinued the following products, which have now been removed from our catalog:
- T100 — Tirzepatide 100 mg
- CBL60 — Cerebrolysin 60 mg
- GTT600 — Glutathione 600 mg
- GTT1200 — Glutathione 1200 mg
- GTT1500 — Glutathione 1500 mg
- AD2 — AOD-9604 2 mg
- AD10 — AOD-9604 10 mg
- BF70 — GLOW Blend with TB-500 Fragment 17–24
- KF80 — KLOW Blend with TB-500 Fragment 17–24
AOD-9604 in the 5 mg strength remains available in our catalog.
Removal of Cerebrolysin and Glutathione
The removal of Cerebrolysin and Glutathione is related to their regulatory classification.
These products are registered pharmaceutical drugs and were previously supplied as finished pharmaceutical products. Due to increasingly strict regulatory requirements governing this category, they can no longer be distributed within the framework used for research substances and chemical reagents.
This decision is related exclusively to regulatory and supply requirements and is not connected to any concerns regarding product quality.
Newly Added Products
The following products have been added to our catalog and are now available for ordering:
- FMP2 — PEG-MGF 2 mg
- 22-10 — PE22-28 10 mg
- AX — Adamax 10 mg, 984 Da version
- MS20 — MOTS-c 20 mg
The current availability and pricing for each product can be found directly in the product catalog.
China Peptides Sourcing Perspective
For catalog listings, batch specifications, and ordering information, see the catalog or how sourcing works.